MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
$392,593K
(13.92%↑ Y/Y)
Depreciation and
amortization
$49,885K
(7.42%↑ Y/Y)
Stock-based compensation
costs
$28,938K
(27.85%↑ Y/Y)
Inventories
-$26,129K
(-441.96%↓ Y/Y)
Amortization of right-of-use
assets
$12,445K
(31.51%↑ Y/Y)
Accounts payable,
accrued expenses,...
$10,645K
(152.25%↑ Y/Y)
Net cash provided by
(used in) operating...
$339,745K
(10.08%↑ Y/Y)
Effect of exchange rate
changes on cash
$2,767K
(109.60%↑ Y/Y)
Canceled cashflow
$179,881K
Net increase
(decrease) in cash and cash...
$33,221K
(-65.24%↓ Y/Y)
Canceled cashflow
$309,291K
Prepaid expenses, net
deferred income taxes and...
$106,387K
(143.88%↑ Y/Y)
Accounts receivable
$72,682K
(7.12%↑ Y/Y)
(gain) loss
attributable to equity method...
$506K
(150.15%↑ Y/Y)
(gain) loss on equity
investments (note 5)
$306K
(121.26%↑ Y/Y)
Proceeds from issuance of
common stock, net
$29,557K
(9.97%↑ Y/Y)
Purchases of intangible
assets
-$1,335K
(-147.26%↓ Y/Y)
Proceeds from exits of
investments (note 5)
$250K
(0.00%↑ Y/Y)
Net cash provided by
(used in) financing...
-$258,349K
(-75.11%↓ Y/Y)
Net cash provided by
(used in) investing...
-$50,942K
(-38.84%↓ Y/Y)
Canceled cashflow
$29,557K
Canceled cashflow
$1,585K
Purchases of treasury
stock
$175,014K
(133.40%↑ Y/Y)
Dividends paid
$87,584K
(12.73%↑ Y/Y)
Purchases of property,
plant and equipment
$28,539K
(38.24%↑ Y/Y)
Proceeds (payments) on
maturity of foreign...
$12,406K
(5.11%↑ Y/Y)
Patent registration
and acquisition...
$7,351K
(160.21%↑ Y/Y)
Purchases of investments
(note 5)
$4,231K
(323.10%↑ Y/Y)
Taxes paid related to
net share...
$20,308K
(21.36%↑ Y/Y)
Repayment of borrowings
$5,000K
(0.00%↑ Y/Y)
Back
Back
Cash Flow
source: myfinsight.com
logo-resmed-color-svg
RESMED INC (RMD)
logo-resmed-color-svg
RESMED INC (RMD)